Terms: = Skin cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Prognosis
10 results:
1. Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma.
Wang Q; Liu W; Zhou H; Lai W; Hu C; Dai Y; Li G; Zhang R; Zhao Y
Neoplasia; 2024 Feb; 48():100966. PubMed ID: 38237304
[TBL] [Abstract] [Full Text] [Related]
2. prognosis of CDKN2A germline mutation in patients with familial melanoma: a systematic review and meta-analysis.
Taibo A; Paradela S; Suanzes-Hernández J; Balboa-Barreiro V; Amado-Bouza J; Fonseca E
Melanoma Res; 2024 Feb; 34(1):9-15. PubMed ID: 37924530
[TBL] [Abstract] [Full Text] [Related]
3. Clinical features and factors affecting prognosis and partial deterioration of ocular papilloma: a retrospective study of 298 cases.
Jian H; He W
Graefes Arch Clin Exp Ophthalmol; 2023 Aug; 261(8):2395-2402. PubMed ID: 36933010
[TBL] [Abstract] [Full Text] [Related]
4. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
Front Immunol; 2022; 13():967277. PubMed ID: 36466837
[TBL] [Abstract] [Full Text] [Related]
5. Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using
Kitajima K; Watabe T; Nakajo M; Ishibashi M; Daisaki H; Soeda F; Tanemura A; Kanekura T; Yamazaki N; Ito K
Jpn J Radiol; 2022 Jan; 40(1):75-85. PubMed ID: 34287739
[TBL] [Abstract] [Full Text] [Related]
6. Obesity is not associated with disease-free interval, melanoma-specific survival, or overall survival in patients with clinical stage IB-II melanoma after SLNB.
Deckers EA; Kruijff S; Bastiaannet E; van Ginkel RJ; Hoekstra-Weebers JEHM; Hoekstra HJ
J Surg Oncol; 2021 Sep; 124(4):655-664. PubMed ID: 34085291
[TBL] [Abstract] [Full Text] [Related]
7. cd74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival.
Zeiner PS; Zinke J; Kowalewski DJ; Bernatz S; Tichy J; Ronellenfitsch MW; Thorsen F; Berger A; Forster MT; Muller A; Steinbach JP; Beschorner R; Wischhusen J; Kvasnicka HM; Plate KH; Stefanović S; Weide B; Mittelbronn M; Harter PN
Acta Neuropathol Commun; 2018 Mar; 6(1):18. PubMed ID: 29490700
[TBL] [Abstract] [Full Text] [Related]
8. A case of cutaneous malignant fibrous histiocytoma with multiple organ metastases.
Suzuki S; Watanabe S; Kato H; Inagaki H; Hattori H; Morita A
Kaohsiung J Med Sci; 2013 Feb; 29(2):111-5. PubMed ID: 23347814
[TBL] [Abstract] [Full Text] [Related]
9. Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases.
Santucci M; Pimpinelli N; Arganini L
Cancer; 1991 May; 67(9):2311-26. PubMed ID: 2013039
[TBL] [Abstract] [Full Text] [Related]
10. Acral (volar-subungual) melanoma in Auckland, New Zealand.
Shaw JH; Koea JB
Br J Surg; 1988 Jan; 75(1):69-72. PubMed ID: 3337957
[TBL] [Abstract] [Full Text] [Related]
